SCHEMBL25519641

SCHEMBL25519641

CC(C)c1cccc2cc(F)c(O)nc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 3/20 0.44
▸ LMNA P02545 3/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ TSHR P16473 2/20 0.44
▸ GABRB2 P47870 2/20 0.44
▸ GABRG2 P18507 2/20 0.44
▸ GABRB3 P28472 2/20 0.44
▸ FAAH O00519 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ GABRB1 P18505 1/20 0.44
▸ PTGS1 P23219 1/20 0.44
▸ SLC6A2 P23975 1/20 0.44
▸ HTR2C P28335 1/20 0.44
▸ GABRA5 P31644 1/20 0.44
▸ GABRA3 P34903 1/20 0.44
▸ HTR2B P41595 1/20 0.44
▸ GABRA2 P47869 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20047538 0.79 CYP1A2 (0.39) GABRA1LMNACYP1A2CYP3A4HPGD
SCHEMBL25523412 0.74 AHR (0.35) KDM4ERPS6KA3L3MBTL1
SCHEMBL21173381 0.73 CYP1A2 (0.48) GABRA1LMNACYP1A2CYP3A4HPGD
SCHEMBL25520946 0.72 GABRA1 (0.44) GABRA1GABRB2KDM4E
SCHEMBL25522217 0.72 RPS6KA3 (0.35) KDM4ERPS6KA3
SCHEMBL1186316 0.71 HPGD (0.50) GABRA1LMNACYP1A2CYP3A4HPGD
SCHEMBL24632434 0.69 GABRA1 (0.44) GABRA1LMNACYP1A2CYP3A4HPGD
SCHEMBL7573609 0.69 ALDH1A1 (0.44) LMNACYP1A2CYP3A4HPGDTSHR
SCHEMBL16674959 0.68 LMNA (0.42) GABRA1LMNACYP1A2CYP3A4HPGD
SCHEMBL27417063 0.68 PARP1 (0.53) CYP1A2CYP3A4HPGDTSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086428-A2 NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2023-05-19 — — WO disclosed
Send feedback